Breaking News Instant updates and real-time market news.

PCG

PG&E

$48.48

0.55 (1.15%)

15:19
10/09/18
10/09
15:19
10/09/18
15:19

PG&E responds to Cascade wildfire announcement

Pacific Gas and Electric Company issued the following statement in response to the release of information by the California Department of Forestry and Fire Protection, or CAL FIRE, regarding the October 2017 Cascade wildfire: "The safety of our customers, their families and the communities we serve is our most important job. Without question, the loss of life, homes and businesses in these extraordinary wildfires is heartbreaking and we remain focused on helping communities recover and rebuild. As independent experts have confirmed, extreme weather, years of drought, and millions of dead trees are feeding an unprecedented risk of wildfires. In light of this, we recognize we all need to do even more to help reduce the risk of wildfires, and are committed to working together with our state and community partners to develop comprehensive safety solutions for the future. We look forward to the opportunity to carefully review the CAL FIRE report to understand the agency's perspectives. In the meantime, we are continuing to focus on implementing additional precautionary measures intended to further reduce wildfire threats, such as working to remove and reduce dangerous vegetation, improving weather forecasting, upgrading emergency response warnings, making lines and poles stronger in high fire threat areas and taking other actions to make our system, and our customers and communities, even safer in the face of a growing wildfire threat."

  • 11

    Nov

PCG PG&E
$48.48

0.55 (1.15%)

09/06/18
09/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ANALYSTS WEIGH IN ON MICRON: Despite recent softness in DRAM spot pricing, the more appropriate metric for Micron Technology (MU) investors to focus on is gross margin, Deutsche Bank analyst Sidney Ho said. On gross margin, the analyst sees Micron benefiting from "solid cost improvement through technology transition" in fiscal 2019. Further, he believes the DRAM market has become more diverse, which should help offset temporary weakness in any given end market. As the company continues to execute on its technology roadmap and delivers solid operating results, Ho expects Micron's stock valuation to re-rate. He kept a Buy rating and $80 price target on Micron. However, Baird analyst Tristan Gerra said Micron is no longer a top large-cap idea, citing its valuation and the likelihood gross margins may be nearing their peak. He also noted DRAM pricing is likely peaking and NAND is in significant oversupply. Gerra maintained an Outperform rating but lowered his price target to $75 from $100 on Micron shares. ARGUS UPGRADES PG&E TO BUY: Argus analyst Jacob Kilstein upgraded PG&E (PCG) to Buy from Hold with a price target of $54, saying the company's recent California legislative victory will reduce its liability for last year's wildfire as its earnings outlook improves. Kilstein further anticipates PG&E to announce a timeline regarding its dividend reinstatement after being forced to suspend its quarterly payout on concerns about its potential wildfire damage responsibility estimated as high as $12B. NORTHLAND DOWNGRADES TILRAY TO MARKET PERFORM: Northland analyst Mike Grondahl downgraded Tilray (TLRY) to Market Perform from Outperform. While he continues to see the company playing a "huge role" in the recreational-use cannabis market in Canada and other countries and the medical market in Europe, he also believes the risk/reward is far more balanced following the recent "massive" move in the stock. JPMORGAN CUTS FRANKLIN RESOURCES TO UNDERWEIGHT: JPMorgan analyst Kenneth Worthington downgraded Franklin Resources (BEN) to Underweight from Neutral and lowered his price target for the shares to $29 from $32. The analyst believes the more recent weakness in emerging markets, and in particular in emerging market debt, will weigh on both Franklin's organic growth and earnings potential. He thinks challenges in emerging markets put additional pressure on "an already challenging growth story characterized by weak fund performance, significant outflows, and declining margins." Worthington continues to have a negative view on the asset management sector.
09/06/18
09/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PG&E (PCG) upgraded to Buy from Hold at Argus with analyst Jacob Kilstein saying the company's recent California legislative victory will reduce its liability for last year's wildfire as its earnings outlook improves. 2. Arrowhead (ARWR) upgraded to Buy from Neutral at B. Riley FBR with analyst Madhu Kumar saying while the data presented this morning are early, they provide clinical proof of concept for Arrowhead's current hepatitis B virus franchise. 3. TSYS (TSS) upgraded to Outperform from Perform at Oppenheimer with analyst Glenn Greene saying he remains optimistic regarding the company's growth outlook and improving business mix going forward. 4. Vodafone (VOD) upgraded to Buy from Neutral at Citi with the firm saying it sees near-term upside in the shares amid improving conditions in Germany. 5. Inseego (INSG) upgraded to Buy from Hold at Canaccord with analyst T. Michael Walkley citing his 2020 estimates, which he raised following meetings with management. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/18
ARGS
09/06/18
UPGRADE
Target $54
ARGS
Buy
PG&E upgraded to Buy at Argus after its California legislative win
As reported earlier, Argus analyst Jacob Kilstein upgraded PG&E to Buy from Hold with a price target of $54, saying the company's recent California legislative victory will reduce its liability for last year's wildfire as its earnings outlook improves. The analyst also raised his FY18 EPS view to $3.82 from $3.72, while noting that the company's valuation of 12.3-times his expected FY18 earnings is well below the industry average of 18.1-times. Kilstein further anticipates PG&E to announce a timeline regarding its dividend reinstatement after being forced to suspend its quarterly payout on concerns about its potential wildfire damage responsibility estimated as high as $12B.
09/06/18
ARGS
09/06/18
UPGRADE
ARGS
Buy
PG&E upgraded to Buy from Hold at Argus

TODAY'S FREE FLY STORIES

C

Citi

$64.03

-0.28 (-0.44%)

11:00
02/22/19
02/22
11:00
02/22/19
11:00
Options
Active trading in Citigroup short-term puts »

Active trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Apr

  • 28

    May

  • 13

    Jul

ZG

Zillow

$40.54

5.47 (15.60%)

, Z

Zillow

$40.94

5.91 (16.87%)

10:57
02/22/19
02/22
10:57
02/22/19
10:57
Periodicals
Citron says now positive on Zillow, calls returning CEO a 'stud' »

Citron Research tweeted:…

ZG

Zillow

$40.54

5.47 (15.60%)

Z

Zillow

$40.94

5.91 (16.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

ZG

Zillow

$40.54

5.47 (15.60%)

, Z

Zillow

$40.94

5.91 (16.87%)

10:57
02/22/19
02/22
10:57
02/22/19
10:57
Periodicals
Breaking Periodicals news story on Zillow, Zillow »

Citron Research turns…

ZG

Zillow

$40.54

5.47 (15.60%)

Z

Zillow

$40.94

5.91 (16.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

PFE

Pfizer

$43.02

0.88 (2.09%)

10:55
02/22/19
02/22
10:55
02/22/19
10:55
Periodicals
Pfizer exec to host presidential fundraiser for Gillibrand campaign, CNBC says »

Pfizer's executive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

PLNT

Planet Fitness

$59.40

1.14 (1.96%)

10:50
02/22/19
02/22
10:50
02/22/19
10:50
Options
Earnings hedge opened in Planet Fitness »

Earnings hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

FDX

FedEx

$178.46

-3.82 (-2.10%)

, AMZN

Amazon.com

$1,625.63

5.79 (0.36%)

10:44
02/22/19
02/22
10:44
02/22/19
10:44
On The Fly
Stamps.com plummets after announcing discontinuation of USPS partnership »

Shares of Stamps.com…

FDX

FedEx

$178.46

-3.82 (-2.10%)

AMZN

Amazon.com

$1,625.63

5.79 (0.36%)

STMP

Stamps.com

$84.82

-113.26 (-57.18%)

UPS

UPS

$109.32

-2.44 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

TROX

Tronox

$11.80

0.45 (3.96%)

10:40
02/22/19
02/22
10:40
02/22/19
10:40
Options
Bullish call flow in Tronox ahead of earnings next week »

Bullish call flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

10:40
02/22/19
02/22
10:40
02/22/19
10:40
General news
Fed's Williams: the Phillips Curve is "alive and well" »

Fed's Williams: the…

C

Citi

$64.24

-0.07 (-0.11%)

, INTC

Intel

$52.73

1.33 (2.59%)

10:39
02/22/19
02/22
10:39
02/22/19
10:39
On The Fly
Citi, Intel upgrades, Roku, Nordstrom downgrades among today's top analyst calls »

Check out today's top…

C

Citi

$64.24

-0.07 (-0.11%)

INTC

Intel

$52.73

1.33 (2.59%)

ROKU

Roku

$59.51

8.04 (15.62%)

JWN

Nordstrom

$43.50

-0.97 (-2.18%)

KHC

Kraft Heinz

$34.95

-13.24 (-27.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 06

    Mar

  • 25

    Mar

  • 26

    Mar

  • 15

    Apr

  • 28

    May

  • 13

    Jul

EA

Electronic Arts

$93.86

-2.97 (-3.07%)

10:37
02/22/19
02/22
10:37
02/22/19
10:37
Periodicals
EA starts massive round of layoffs at Australian studio, Kotaku reports »

Electronic Arts has begun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

PYX

Pyxus

$24.70

-1.46 (-5.58%)

10:36
02/22/19
02/22
10:36
02/22/19
10:36
Initiation
Pyxus initiated  »

Pyxus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$31.60

0.26 (0.83%)

10:30
02/22/19
02/22
10:30
02/22/19
10:30
Options
Downside hedge opened in Xerox April options »

Downside hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$149.39

32.25 (27.53%)

10:29
02/22/19
02/22
10:29
02/22/19
10:29
Recommendations
Wayfair analyst commentary  »

Wayfair price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

10:26
02/22/19
02/22
10:26
02/22/19
10:26
General news
Stocks higher as trade talks continue »

Stock futures were higher…

ACER

Acer Therapeutics

$24.25

0.38 (1.59%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Jun

AVEO

Aveo Pharmaceuticals

$0.62

0.0006 (0.10%)

, BMY

Bristol-Myers

$50.47

0.32 (0.64%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

AVEO

Aveo Pharmaceuticals

$0.62

0.0006 (0.10%)

BMY

Bristol-Myers

$50.47

0.32 (0.64%)

EXEL

Exelixis

$21.28

0.06 (0.28%)

IMMU

Immunomedics

$14.34

0.01 (0.07%)

JNJ

Johnson & Johnson

$135.83

0.43 (0.32%)

MRK

Merck

$80.55

0.73 (0.91%)

NKTR

Nektar

$40.10

-0.16 (-0.40%)

PFE

Pfizer

$42.89

0.75 (1.78%)

SGEN

Seattle Genetics

$69.99

0.74 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

  • 11

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Cowen consumer analysts to hold an analyst/industry conference call »

Consumer Analysts Kernan…

XEC

Cimarex Energy

$73.78

0.45 (0.61%)

, REN

Resolute Energy

$31.93

0.41 (1.30%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Resolute Energy to host special shareholder meeting »

Special Shareholder…

XEC

Cimarex Energy

$73.78

0.45 (0.61%)

REN

Resolute Energy

$31.93

0.41 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 04

    Mar

  • 22

    May

LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

, QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Quad/Graphics to host special shareholder meeting »

Special Shareholder…

LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

, LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
LSC Communications to host special shareholder meeting »

Special Shareholder…

QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

ELGX

Endologix

$0.54

0.0223 (4.27%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

ACAM

Acamar Partners

$0.00

(0.00%)

10:23
02/22/19
02/22
10:23
02/22/19
10:23
Syndicate
Acamar Partners opens at $10.01, IPO priced at $10.00 per share »

Acamar Partners (ACAM)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

DPLO

Diplomat Pharmacy

$8.56

-4.905 (-36.44%)

10:23
02/22/19
02/22
10:23
02/22/19
10:23
Downgrade
Diplomat Pharmacy rating change  »

William Blair downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

ECC

Eagle Point Credit

$16.99

0.24 (1.43%)

10:21
02/22/19
02/22
10:21
02/22/19
10:21
Downgrade
Eagle Point Credit rating change  »

Eagle Point Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$88.83

0.32 (0.36%)

10:20
02/22/19
02/22
10:20
02/22/19
10:20
Options
Call buyers in LyondellBasell as shares see strength »

Call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.